MARKET

ROIV

ROIV

Roivant Sciences
NASDAQ
41.19
+0.52
+1.28%
After Hours: 41.19 0 0.00% 19:30 11/10 EST
OPEN
40.60
PREV CLOSE
40.67
HIGH
41.37
LOW
39.88
VOLUME
10.59M
TURNOVER
--
52 WEEK HIGH
42.50
52 WEEK LOW
19.79
MARKET CAP
29.75B
P/E (TTM)
-105.8053
1D
5D
1M
3M
1Y
5Y
1D
Priovant announces publication of Phase 2 BEACON results for brepocitinib
TipRanks · 12h ago
Roivant Sciences price target raised to $48 from $47 at H.C. Wainwright
TipRanks · 13h ago
Roivant Sciences price target raised to $42 from $41 at BofA
TipRanks · 14h ago
Nvidia To $300? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga · 17h ago
Analysts Are Bullish on These Healthcare Stocks: Roivant Sciences (ROIV), Neurogene (NGNE)
TipRanks · 17h ago
Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Definitive Healthcare Corp (DH) and Myriad Genetics (MYGN)
TipRanks · 19h ago
Roivant Sciences Price Target Raised to $48.00/Share From $47.00 by HC Wainwright & Co.
Dow Jones · 19h ago
Roivant Sciences Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 19h ago
More
About ROIV
Roivant Sciences Ltd. is a biopharmaceutical company focused on improving the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.

Webull offers Roivant Sciences Ltd stock information, including NASDAQ: ROIV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ROIV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ROIV stock methods without spending real money on the virtual paper trading platform.